4.2. Analysis.
Comparison 4: Cardiovascular mortality at maximum follow‐up, Outcome 2: Cardiovascular mortality ‐ Type of beta‐blocker
Comparison 4: Cardiovascular mortality at maximum follow‐up, Outcome 2: Cardiovascular mortality ‐ Type of beta‐blocker